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Abstract
This paper examines the levels of health system efficiency and their possible determinants
across Latin American and Caribbean (LAC) countries using national-level data for those
countries, as well as for other emerging and developed countries. The data are analyzed
using data envelopment analyses and econometric advances that yield reliable estimations
of the relationship between system efficiency and its potential determinants. We find that
there is substantial room for efficiency improvements in the health system of most LAC
countries. For example, LAC countries could improve life expectancy at birth by about five
years on average at current public spending levels if they followed best practices. Further-
more, the paper assesses what factors amenable to policy act as the main possible levers
for some countries to be able to translate a given level of health financing into better perfor-
mance on access to care and health outcomes. Our econometric analyses suggest that
efforts to increase health system efficiency could be focused in a few key policy areas asso-
ciated with broader access to health services and better outcomes. These areas include
general governance aspects, in addition to improvements in specific dimensions of the qual-
ity of health system institutions, notably stronger reliance on results-based management in
the production of healthcare goods and services.
Introduction
During most of the 2000s, the majority of Latin America and Caribbean (LAC) economies
experienced sustained growth and improvements in social indicators, as shown by the evolu-
tion of real GDP growth and poverty reduction data [1]. Yet this trend has stalled in many
LAC countries since the onset of the global financial crisis in 2008 and, despite recent progress,
social inequalities remain pervasive in the region, with World Bank data on Gini indices plac-
ing 10 LAC countries among the 15 most unequal in terms of income distribution [1].
The situation in the health sector closely mirrors the panorama described above. As a gen-
eral rule, LAC countries have over a 20 year period achieved great improvements in health and
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well-being. Average life expectancy has been rising significantly for example, while under-five
mortality rates have been consistently reduced (Fig 1). Health systems have likely been a cru-
cial driver of this progress through a widening of access to necessary health services for citi-
zens. Utilization measures commonly used as proxies for access to needed services, such as
coverage of skilled birth attendance and immunization rates, have improved continuously dur-
ing the 2000s (Fig 1).
Much of this health progress has taken place within the global push for universal health cov-
erage (UHC). Yet progress towards UHC entails not only aggregate improvements in service
access and health outcomes; at the center of this health agenda is also the drive to address
unmet needs and health inequities [2]. A massive 125 million people in the LAC region still
lack access to basic health services [3]. Health inequities persist among and within countries:
some countries in the region exhibit far better progress than others judged by average
improvements in key indicators, and in many instances health improvements have occurred
favoring certain population groups at a disproportionate rate. For example, Haitians are
expected to live 62 years on average, as compared to 79 years for Costa Ricans, and while
under-five mortality is as low as 5.5 per 1,000 live births in Cuba, this figure reaches 39.4 per
1,000 live births in Guyana. Maternal mortality in rural areas in Bolivia is twice as high as in
more urban areas, a pattern replicated in many other LAC countries [1, 3, 4].
The mixed health results achieved by LAC countries individually have taken place within
a general context of increasing pressure on health budgets. Although the average share of pub-
lic spending directed to the health sector among LAC countries has increased by as much as
41% between 2000–2012, cost pressures arising from technological advances and changes to
Fig 1. Selected health outcomes and coverage indicators in LAC (1995–2014).
https://doi.org/10.1371/journal.pone.0216620.g001
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demographic and epidemiological profiles mean that there will be continuing pressures for
health expenditure to grow at rates above economic growth in many countries of the region
[5]. In LAC, as in other regions of the world, countries vary significantly in terms of the
population health indicators achieved for similar amounts of resources devoted to health (see
Methods and data). Understanding the reasons for these differences in performance represents
an essential step to the development of policies that ensure sustained progress towards UHC
and health for all. This is an even more pressing need in the challenging economic context cur-
rently faced by many LAC countries, constraining public expenditures and public spending on
health in particular.
There is now a good amount of evidence available about the relative levels of efficiency in
the health sector of high-income countries [6, 7]. A recent review of the literature and other
studies have concluded that there is evidence of widespread inefficiencies in the health sector
of several OECD countries that help explain their differences in health attainment [8, 9]. These
inefficiencies relate to factors including imbalances in physical and human resources relative
to health needs, inadequate access to health prevention and promotion activities, and institu-
tional factors such as deficient data collection and weak governance of the health system. By
contrast, there is very little accumulated evidence on the degree and (particularly) determi-
nants of health system efficiency in the LAC region as a whole, except for ad-hoc analyses of
specific sectors in a few particular countries [10–15]. Some studies have attempted to measure
health system efficiency using samples that include all world countries with available data,
focusing often on comparisons of average efficiency across regions [16–21]. Invariably, these
studies point to high levels of variation across countries in terms of efficiency performance
and significant room for advances in health indicators through health system efficiency
improvements.
However, such studies offer limited reliable evidence able to guide policy on how efficiency
improvements could be achieved–either because of a lack of focus on identifying potential
determinants of efficiency variations, or because of methodological limitations in attempting
to do so. This applies not only to evidence regarding LAC countries but also to LMICs more
generally. First, there is scant guidance in the cross-country literature about which factors
under more direct policy control can be leveraged to improve health system efficiency. Even
when previous studies have examined factors correlated with efficiency performance, such fac-
tors have usually been proxied by indicators that are too broad, or have very limited direct rela-
tionship with the functioning of the health system, to be of useful guidance for policymakers
(e.g. urbanization, income distribution). Second, the influence of factors pertaining to the
organization of healthcare delivery and the quality of health system institutions, found to be
important for explaining variations in healthcare costs and efficiency in OECD countries [7,
22–24], has not been assessed systematically in a LMIC context using cross-country data.
Third, although existing studies have examined health spending efficiency relative to some
important health indicators (e.g. life expectancy), they have usually ignored other key outputs
of the health system, particularly those related to access to care and equity of access to ser-
vices–fundamental components of the UHC and SDG agendas [2, 25].
Our study uses LAC data to address some of the knowledge gaps mentioned above. Our
goal is to identify the levels of health system efficiency and their possible determinants across
LAC countries, as well as to provide insights into the quantitative influence of these potential
determinants on observed levels of health system efficiency in the region. The measurement of
‘efficiency’ in the health sector has multiple connotations, depending on the entity under scru-
tiny and the decisions it is intended to support [26]. In this paper we address the concept of
system level efficiency, understood as the extent to which resources devoted to the health sec-
tor succeed in securing health improvement, a prime concern of national policymakers
Potential determinants of health system efficiency
PLOS ONE | https://doi.org/10.1371/journal.pone.0216620 May 10, 2019 3 / 21
charged with stewardship of the entire health system. We contribute to the knowledge base by:
performing head-to-head comparisons of health system efficiency based on several outputs
(health outcomes, care access and equity of access) for all LAC countries; benchmarking the
results for LAC against other emerging and developed economies; and investigating possible
system efficiency determinants related to the organization of healthcare financing and delivery,
quality of governance, and quality of health system institutions in specific areas. This adds to
our application of methodological advances that favor more reliable estimations of the rela-
tionship between system efficiency and its potential determinants.
Methods and data
Data envelopment analysis of health system efficiency
Methodology. Our study uses data envelopment analysis (DEA) to analyze efficiency in
the achievement of health system objectives and its relationship with certain system character-
istics at the country level. DEA is based on the economic principles of cost and production
functions, and searches for the units that ‘envelop’ all other units on the basis of a composite
estimate of efficiency [27]. For each unit–a country and its health system in our case–the ratio
of actual to ‘optimal’ performance (or best practice) is referred to as inefficiency. As detailed
below, we measure performance through health outcomes and access to care indicators, and
the main input in our models is public health spending per capita. Throughout, our analyses
use the ‘output orientation’ approach to DEA and the recommended model specification set
out by Banker, Charnes and Cooper when variables are specified as ratios [28]. The output ori-
entation indicates the extent to which a better performance on indicators of access to care and
health outcomes could be obtained while still maintaining the same level of health expendi-
tures. In simple terms, our approach identifies those countries that achieve the best perfor-
mance on output indicators for their level of public health spending per capita, comparing
other countries in relation to these ‘best performing’ countries.
Compared to statistical methods DEA has some attractive features, particularly in that it
requires none of the stringent model testing that is required of statistical techniques. DEA
studies need to be parsimonious in the selection of inputs however, as the inclusion of more
inputs or constraints offers countries more potential ‘excuses’ for lower levels of performance,
reducing the capacity to discriminate among countries and their health systems. Our study
examines a range of modelling options in order to identify the sensitivity of judgments to dif-
ferent technical choices, including alternative sets of inputs and outputs.
Country samples. Our LAC sample contains annual information for the period 2006–
2015 for 27 LAC countries. In order to be able to benchmark the efficiency performance of
LAC countries, we use an extended sample that includes (in addition to the 27 LAC countries)
32 OECD countries and 12 non-OECD, non-LAC middle-income countries (MICs), totaling
71 countries with the inclusion of LAC. Although this extended sample forms the basis of
our analysis, our presentation of results focuses on the performance of the LAC countries.
Table A1 in S1 Appendix presents the full list of countries. The indicators used in our DEA
estimations, along with their sources and five-year average values for the relevant periods, are
described below and in Tables A2 and A3 in S1 Appendix.
Output indicators. Wemeasure health system performance primarily with regard to
broad indicators of population health status. These are complemented by key measures of
progress towards UHC–service coverage indicators–agreed in the UHCmonitoring frame-
work [29], and we also acknowledge the relevance of assessing health system performance
from the perspective of equity in access to necessary care [2]. Specifically, for the main estima-
tions we run separate DEA models for each of the outputs below:
Potential determinants of health system efficiency
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1. Health outcomes: life expectancy at birth (years); life expectancy at age 60 (years); under-
five mortality rate (per 1,000 live births); and disability-adjusted life years lost (DALYs, all
causes, age-standardized, per 100,000 population);
2. Access to services: skilled birth attendance (percentage of deliveries) and DPT immuniza-
tion rate (percentage of children aged 12–23 months);
3. Equity of access to services: ratio poorest/richest wealth quintiles of births attended by
skilled health staff; ratio rural/urban of births attended by skilled health staff.
The DEA methodology requires that output variables are measured in a way that indicates
that ‘more is better’, so in the estimations we use the inverse of the under-five mortality rate
and DALYs lost. We proxy general access to the health system through rates of utilization of
services that should be provided to entire population groups, skilled birth attendance and DPT
vaccination; together, these two proxies provide some indication of the conditions of access
to the broader basket of services provided in a health system [30]. The most recent years for
which the relevant country information is available varies by indicator. For output indicators
we use five-year averages (2011–2015) in the DEA estimations, instead of their most recent val-
ues (except for DALYs and the equity of access measures, which are often available for just a
single year between 2011–2015). The use of five-year averages is primarily for two reasons.
First, the averaging procedure reduces the influence of extreme values (outliers) observed for
countries due to, for example, one-off epidemiological or economic shocks and/or data mea-
surement errors. Second, using averages allows us to explore data on specific indicators for
more countries than using just the latest data (e.g. skilled birth attendance). We note that using
the median output values instead of averages for the same period leads to very similar DEA
efficiency scores, and virtually unchanged rankings of countries’ efficiency (the correlation
coefficients between the two sets of efficiency scores for each output range from 0.89 to 0.99).
Input indicators. We assess the extent to which countries differ in the success with which
their health system funds achieve a given level of performance. It is likely that the observed effi-
ciency of LAC health systems is related principally to public funding, since governments typi-
cally have a major role in health system functions in the LAC region. Our study therefore uses
public health expenditure per capita at PPP constant 2011 international dollars as the spending
input in the main analyses. It consists of recurrent and capital spending from government
(central and local) budgets, external borrowings and grants (including donations from inter-
national agencies and nongovernmental organizations), and social (or compulsory) health
insurance funds. In robustness checks we use total health expenditure per capita or pooled pre-
paid health expenditure per capita as the main input instead.
We use five-year averages of our health expenditure measures in the DEA for the reasons
discussed previously. Unlike outputs, however, we measure inputs as 2006–2010 averages.
This is intended to reflect empirical evidence about time lags in the causal chain between
health spending, changes in service access and quality, and consequent improvements in
health outcomes at the country level [18, 31]. As can be seen in Fig 2, the health achievements
of individual LAC countries vary considerably in the study period with regard to public health
spending, with high spenders not necessarily being always the best performers. For example,
Costa Rica and Trinidad and Tobago spend similar amounts per person but the former coun-
try records a much higher life expectancy and significantly lower under-five mortality than the
latter.
External constraints (other inputs). A country’s ability to maximize the impact of a given
level of financial resources on health system outcomes is likely to be affected by economic
and social development factors. Many of these factors may be uncontrollable influences on
Potential determinants of health system efficiency
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Fig 2. Life expectancy, under-five mortality and public health expenditure per capita in LAC.
https://doi.org/10.1371/journal.pone.0216620.g002
Potential determinants of health system efficiency
PLOS ONE | https://doi.org/10.1371/journal.pone.0216620 May 10, 2019
attainment and completely external to the health system. We therefore also include as addi-
tional inputs (constraints) in the DEAmodels:
1. National income: GDP per capita (constant 2011 PPP international dollars);
2. Age structure/demographics: population aged 65 and above (percentage of total).
As in the case of health spending measures, in the DEA estimations we use five-year aver-
ages 2006–2010 of GDP per capita and (the inverse of) the share of population aged 65. We
also experimented with alternative specifications including further external constraints on
performance, such as education achievement (average years of total schooling, age 15+),
improved water source (percentage of population with access) and improved sanitation facili-
ties (percentage of population with access). However, these indicators are highly correlated
with GDP per capita in our sample (pairwise correlation coefficients ranging between 0.6 and
0.7, p<0.01), hence adding limited additional information to the models, and leading to an
unwarranted inflation in the number of countries on the efficiency frontier. For these reasons,
they have not been included in the analyses below. Finally, we would like to have explored data
on lifestyle factors such as alcohol consumption and smoking prevalence as additional perfor-
mance constraints, but these figures are unavailable for a large number of LAC countries.
The DEAmodels. We estimate three alternative DEAmodels for each health system output
analyzed separately. Model (1) has public health spending per capita as the sole input. Model (2)
includes public health spending per capita and GDP per capita. Finally, model (3) includes pub-
lic health spending per capita, GDP per capita and population aged 65 and above as inputs.
Regression analyses of potential health system efficiency determinants
Methodology. Because DEA efficiency scores are censored with an upper limit of one (or
100%), DEA studies have conventionally modeled the relationship between scores and poten-
tial determinants using a simple censored (Tobit) regression. This approach may lead to incor-
rect statistical inference if–as is often the case–there is high correlation among the estimated
DEA efficiency scores [32]. In this case, using simple Tobit regressions could lead, for instance,
to overstating the precision of estimates of efficiency determinants, leading to erroneous rejec-
tion of the null hypothesis of no statistical association between potential determinants and effi-
ciency scores (which could be behind the high number of statistically significant associations
identified in some studies; see e.g. [16]). A key issue is that the correlation pattern among DEA
efficiency scores is typically complex and unknown.
We provide more reliable estimates of the relationships between various factors and health
system efficiency by using an appropriate regression methodology to analyze DEA efficiency
scores. The approach we adopt, developed by Simar and Wilson [32], accounts for the fact that
DEA efficiency scores are bounded and corrects the standard errors obtained from conven-
tional regression models such as Tobit, by simulating the unknown error correlation among
efficiency scores and calculating bootstrapped standard errors. This method–henceforth
Simar-Wilson–has been employed successfully in some previous efficiency studies focused on
high-income countries [33] and, more recently, central European and central Asian countries
[34]. Here we use Simar-Wilson cross-sectional regressions to estimate the degree of associa-
tion between LAC countries’ average efficiency scores for each output as the dependent vari-
able, and our potential efficiency determinants as explanatory variables. For these regressions,
the estimating sample includes only LAC countries.
Potential efficiency determinants. In order to generate useful insights for policymaking,
the potential efficiency determinants examined in the regressions analyses must refer to policy
choices, as opposed to non-discretionary determinants of health system outputs (beyond
Potential determinants of health system efficiency
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health spending) that should have been captured in the initial DEA efficiency estimations [27].
Our goal is to explain statistically the DEA efficiency scores, investigating systematic associa-
tions between these scores and some discretionary characteristics of LAC health systems.
There are significant limitations for LAC countries regarding comparative data about the orga-
nization of healthcare resources and system institutional factors. Despite these limitations, we
have been able to gather data on some potentially important efficiency determinants, which
can be grouped into three broad categories:
1. Organization of healthcare financing and delivery: out-of-pocket (OOP) health expenditure
share (proportion of total health expenditure); hospital beds (per 1,000 people);
2. Quality of governance: governance indices for six dimensions (government effectiveness;
voice and accountability; rule of law; regulatory quality; political stability and absence of
violence/terrorism; control of corruption); we also construct an average governance index
for the six individual dimensions. Higher indices indicate better performance.
3. Quality of health system institutions: indices for three dimensions (medium-term sectoral
vision for the health system in line with the government plan; results-based management in
the production of goods and services; sectoral information systems); we also construct an
average health system institutional quality index for the three individual dimensions.
Higher indices indicate better performance.
The precise definitions of the indicators above, their sources and sample averages are given
in Tables A2 and A3 in S1 Appendix. The OOP share of health expenditure serves as an indica-
tor of the reliance of health system financing on pooled prepaid revenue sources (or lack
thereof). Revenue raising through prepaid sources such as general taxes and social insurance
contributions has been shown to favor the production of better population health outcomes for
a given health budget [35]. Therefore, a priori, we could expect to find a negative relationship
between the OOP share indicator and system efficiency in our analyses. The hospital beds indi-
cator, on the other hand, may provide information on the availability of physical resources for
the provision of care in a health system; but it may also pick up other aspects such as a country’s
reliance on hospital care compared to primary care. Thus the expected direction of relationship
between hospital beds and efficiency is unclear a priori. Higher quality of governance in a
country is expected to be positively related to the efficiency of its health system [36]. Lastly, the
data on the quality of health system institutions includes assessments of e.g. the existence and
alignment of health system planning with the overall government strategy, as well as availability
of information systems in areas such as healthcare costs and quality. The three main indicators
are computed from various sub-indicators (see Table A2 in S1 Appendix), arguably all of which
can be expected to have a positive impact on efficiency in areas such as continuity of care,
access to timely and clinically effective services, and spending on services [37].
We use the 2006–2010 country-specific average of the indicators 1–3 above in the estimations,
to account for possible lags in the relationship between these indicators and efficiency levels, and
to maintain consistency with the measurement of DEA inputs. The exceptions are the indicators
of quality of health system institutions, for which we use the most reliable series only (year 2013).
Results
Health system efficiency levels within the LAC region
Main DEA results: Efficiency scores and rankings. For conciseness, the summary of the
resulting DEA efficiency scores for the 24 models estimated (three DEA models for each of the
eight health system outputs) is presented in Table A4 in S1 Appendix. The table shows the
Potential determinants of health system efficiency
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average efficiency scores across models (1), (2) and (3) for each country, by output indicator,
along with the number of times each country ranks in the lowest or highest 25% of efficiency
scores (i.e. worst and best performers, respectively) across all models.
The overall message from these estimations is that there is scope for efficiency improve-
ments in the health system of many LAC countries, both in terms of access to care and popula-
tion health indicators. Despite a few good LAC performers, most LAC countries (23) are
located in the bottom half of the average efficiency ranking table across the whole sample. The
best all-round performer in LAC is Chile, which is highly ranked (at 10th) for overall average
efficiency. Chile’s high health system efficiency is driven by its solid performance with respect
to generating good population health outcomes for its level of inputs. Other relatively good
LAC performers in terms of overall health system efficiency include Barbados, Costa Rica and
Cuba. By contrast, some LAC countries are consistently among the worst efficiency performers
across the eight outputs examined, including Bolivia, Guatemala, Guyana and Panama. OECD
countries occupy the large majority of the top 25% positions in terms of average efficiency
score for the eight DEA outputs. However, given their typically higher input levels (especially
health expenditures and national income), OECD countries act as efficient peers for LAC
countries in only very few instances (e.g. Korea and Israel). Most peer pairings for LAC coun-
tries end up occurring among themselves and/or with some good performing MICs at differ-
ent levels of inputs (e.g. China, Sri Lanka and Vietnam).
Fig 3 shows how the average efficiency scores per DEA output compare for the LAC, MICs
and OECD groups. OECD health systems are the most efficient for all DEA outputs consid-
ered, while the non-LACMIC group is the least efficient for all but one of the outputs. Impor-
tant insights arise regarding the comparative efficiency of LAC health systems. On the positive
side, the LAC region outperforms its comparable group of MICs for most health outputs, with
an efficiency performance that is relatively close to that observed in the OECD for some health
outcomes (life expectancy at age 60 and under-five mortality). On the negative side, LAC
health systems perform particularly poorly as far as efficiency in providing equitable access to
services is concerned.
The DEA results reveal the existing scope for many countries to make absolute improve-
ments in health outcomes and access to care that can be very important from a health system
perspective. We illustrate this by computing potential gains per country for each of our eight
system output measures, where potential gains are calculated as the improvement a country
could achieve on its average output indicator if the country moved to the corresponding esti-
mated efficiency frontier (Table 1). In LAC, on average, life expectancy at birth could be
increased by around 5 years–or 7% compared to the region’s average life expectancy–if coun-
tries moved from their current situation to the efficiency frontier, with corresponding figures
of above 8 years for Bolivia, Guyana, Suriname and Trinidad and Tobago. Under-five mortal-
ity could be reduced on average by 10.5 deaths per 1,000 in LAC, which would correspond to
reducing current average under-five mortality in the region by more than one-third, with
potential reductions of between 22 to 25 deaths per 1,000 in Bolivia, Dominican Republic and
Guyana. The indicators of access to the health system could also improve substantially if LAC
countries moved to the efficiency frontier, with a potential increase of 4.5 percentage points on
average for the skilled birth attendance rate, and a potential reduction of almost 12 percentage
points in the gap between the skilled birth attendance rates of the poorest and richest citizens.
As a side note, we also estimated multi-output DEA models where health system efficiency
was assessed with respect to a set of three outputs included simultaneously, namely life expec-
tancy at birth, DPT immunization and the ratio poorest/richest of skilled birth attendance
(one multi-output model estimated for each of the input specifications in our base models
1–3). Unfortunately, the reduced ability to discriminate between more and less efficient
Potential determinants of health system efficiency
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countries in a multi-output DEA setting is as expected quite substantial in our data. Up to 44
out of the 59 countries with available data achieve maximum efficiency in the multi-output
models. As DEA shows countries in the best possible light, good performance for just one out-
put tends to drive several countries to the estimated efficiency frontier (for example, virtually
all OECD countries are deemed fully efficient, chiefly due to their superior efficiency perfor-
mance on service coverage and/or equitable access). Due to the dramatically reduced ability to
discriminate between more and less efficient countries imposed by the mechanics of multi-
output DEA as applied to our data, as well as the fact that in such a specification some coun-
tries secure 100% efficiency by attaching an unreasonably low weight on one or more outputs
(hence contradicting widespread consensus that each of our output domains is an important
element of health system performance [2, 29]), in this study we focus solely on the results of
DEA and regression models estimated separately for each output of interest.
Potential determinants of health system efficiency. The above calculations of potential
gains raise a crucial question from a policymaking viewpoint: what actions could ‘inefficient’
countries take to improve their health system outputs given their current levels of spending?
This question requires some understanding of the main factors influencing measured levels of
health system efficiency in LAC. We use Simar-Wilson cross-sectional regressions to estimate
the degree of association between countries’ average DEA efficiency scores for each output
(from the previous section) as the dependent variable, and our candidate efficiency determi-
nants as explanatory variables. We focus below on the results for three main regression specifi-
cations (Tables 2 and 3). Results for a number of additional specifications are presented in
Fig 3. Comparison of average efficiency scores: LAC, OECD andMICs.
https://doi.org/10.1371/journal.pone.0216620.g003
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Tables A5-A12 in S1 Appendix. The general conclusions are robust across all models so we
concentrate on the main messages.
Health outcomes. Overall, there are few systematic associations between efficiency scores
for health outcomes (life expectancy measures, under-five mortality or DALYs lost) and any of
the indicators of health system organization, governance and institutional quality. The one
notable exception is the positive association between governance quality and system efficiency
with respect to a key health outcome, under five-mortality (Table 2, columns 2–3). This result
is robust to specification changes where the individual health system organization and institu-
tional variables are added (Table A7 in S1 Appendix). We use the most conservative estimated
coefficient in Table 2 (column 2) to provide some intuition on the magnitude of the associa-
tion between governance and system efficiency with respect to under-five mortality. Our
estimation implies that a one-unit increase in the average governance quality indicator is asso-
ciated with an improvement of 0.005 in the efficiency score for under-five mortality. Consider
a comparison between Panama, the ‘better’ country in the third quartile of governance quality
(indicator = 0.100), and Uruguay, which scores in the top quartile of governance quality
Table 1. Potential gains estimated by output indicator.
Country Life expectancy
at birth
(years)
Life expectancy
at age 60
(years)
Under-five
mortality (per
1,000)
DALYs
lost
(per
100,000)
Skilled birth
attendance
(percentage
points)
DPT
immunization
(percentage
points)
Skilled birth
attendance ratio
poorest/richest
(percentage points)
Skilled birth
attendance ratio
rural/urban
(percentage points)
Argentina 5.6 3.01 8.0 6294 2.7 6.4 4.04
Bahamas, The 6.7 3.44 8.6 10562 1.7 2.6
Barbados 5.1 1.75 7.7 5083 1.3 7.5 2.56 1.17
Belize 7.2 2.34 8.4 7243 4.0 4.4 9.46 4.12
Bolivia 8.5 3.46 25.8 14060 11.2 4.3 20.00 18.37
Brazil 6.1 3.07 8.8 8676 2.0 3.5 5.26
Chile 2.0 1.05 1.8 1564 0.3 6.1
Colombia 5.7 0.95 8.9 4696 0.9 9.1 13.24 11.35
Costa Rica 1.7 2.09 3.3 1945 1.7 8.1 3.78 3.69
Cuba 2.5 2.99 1.6 5775 0.4 1.1 1.56
Dominican
Republic
4.4 1.29 22.8 5949 2.4 12.4 2.85 2.55
Ecuador 1.8 1.07 14.3 4990 6.7 13.5 16.37 12.97
El Salvador 5.5 1.73 8.5 10474 1.1 7.9 7.28 3.64
Guatemala 5.5 1.89 19.4 10556 22.8 14.5 23.27 21.97
Guyana 9.4 5.28 25.4 17895 4.6 3.9 12.91 5.31
Haiti 4.2 1.94 7.7 7160 2.0 5.0 2.91 3.18
Honduras 4.1 0.96 5.2 6400 11.3 11.8 16.63 14.28
Jamaica 2.5 2.08 7.6 8633 1.3 7.2 5.76 2.39
Mexico 4.4 2.74 7.2 5152 4.0 8.2 11.38
Nicaragua 2.5 1.76 6.4 5927 6.2 3.5 20.50 11.61
Panama 3.7 1.58 11.5 5935 7.1 15.1 20.80 18.10
Paraguay 4.5 2.04 10.2 5933 3.1 10.3
Peru 3.8 0.53 9.4 3608 11.4 8.7 23.35 20.15
Suriname 8.3 1.38 15.0 7256 11.8 13.09 11.52
Trinidad and
Tobago
10.4 5.10 16.8 15116 0.2 6.6 3.26
Uruguay 4.5 2.64 6.3 7351 2.2 5.5 4.20
Venezuela, RB 5.4 1.09 7.7 6713 4.0 15.1
https://doi.org/10.1371/journal.pone.0216620.t001
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(indicator = 0.756). According to our DEA estimates in the previous sub-section, if Panama
were to improve its governance quality to reach the position of Uruguay among the top 25%
countries (approximately a one-standard deviation jump in the governance indicator), the
resulting increase in Panama’s efficiency score would be equivalent to a reduction of 3.3 deaths
in its under-five mortality rate, for the same level of public health spending.
Table 2. Regression results of potential efficiency determinants: Health outcomes.
Life expectancy Life expectancy at age 60 Under-five mortality (per
1,000)
DALYs lost (per 100,000)
(1) (2) (3) (1) (2) (3) (1) (2) (3) (1) (2) (3)
Out-of-pocket health expenditure (Perc.) 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001
(0.001) (0.001) (0.002) (0.003) (0.001) (0.001) (0.003) (0.003)
Hospital beds (per 1,000 people) 0.002 −0.006 −0.009 −0.016 0.002 −0.001 0.016 −0.005
(0.006) (0.007) (0.020) (0.026) (0.002) (0.001) (0.029) (0.025)
Average governance quality 0.002 0.019 −0.015 0.016 0.005� 0.006� 0.039 0.061
(0.013) (0.015) (0.476) (0.068) (0.003) (0.003) (0.050) (0.060)
Average institutional quality 0.008 0.005 0.035 0.027 0.001 0.001 0.053 0.050
(0.011) (0.010) (0.292) (0.041) (0.002) (0.002) (0.040) (0.040)
Constant 0.912��� 0.914��� 0.904��� 0.906��� 0.856 0.880��� 0.987��� 0.989��� 0.991��� 0.856��� 0.793��� 0.759���
(0.031) (0.028) (0.040) (0.126) (1.428) (0.186) (0.009) (0.005) (0.009) (0.140) (0.100) (0.150)
Observations 27 24 24 27 24 24 27 24 24 27 24 24
Notes: Simar-Wilson models estimated with 1,000 bootstrap replications.
�p<0.1,
��p<0.05,
���p<0.01. Standard errors in parentheses. For under-five mortality, the very small coefficient and standard error for out-of-pocket health expenditure are rounded to
three decimals.
https://doi.org/10.1371/journal.pone.0216620.t002
Table 3. Regression results of potential efficiency determinants: Service access and equity of access.
Skilled birth attendance DPT immunization Skilled birth attendance
ratio poorest/richest
Skilled birth attendance
ratio rural/urban
(1) (2) (3) (1) (2) (3) (1) (2) (3) (1) (2) (3)
Out-of-pocket health expenditure (Perc.) −0.017 −0.015 −0.002�� −0.001 −0.007 −0.005 −0.004 −0.005
(0.018) (0.013) (0.001) (0.001) (0.018) (0.007) (0.006) (0.004)
Hospital beds (per 1,000 people) 0.517� 0.227 0.005 −0.001 0.184 0.142 0.087 0.037
(0.297) (0.173) (0.010) (0.009) (0.360) (0.095) (0.143) (0.059)
Average governance quality 2.536� 0.052 0.030� 0.022 0.507 0.192 0.202 0.061
(1.429) (0.203) (0.017) (0.020) (1.265) (0.186) (0.707) (0.117)
Average institutional quality 0.262 0.135 0.001 0.002 0.008 0.051 0.002 0.019
(0.590) (0.110) (0.013) (0.013) (0.244) (0.097) (0.143) (0.050)
Constant 1.411 3.891 1.244 0.973��� 0.910��� 0.940��� 0.892 1.129 0.817� 0.965�� 1.024 1.035���
(0.945) (3.720) (0.778) (0.047) (0.035) (0.057) (1.586) (4.302) (0.479) (0.386) (1.314) (0.274)
Observations 26 23 23 27 24 24 19 18 18 21 19 19
Notes: Simar-Wilson models estimated with 1,000 bootstrap replications.
�p<0.1,
��p<0.05,
���p<0.01. Standard errors in parentheses.
https://doi.org/10.1371/journal.pone.0216620.t003
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Service access and equity of access. We find only weak associations between the service
access efficiency scores and the OOP share or hospital beds indicators. While a couple of statis-
tically significant results in Table 3 (column 1) suggest that higher shares of OOP expenditures
(for DPT immunization) and lower number of beds (for skilled birth attendance) are associ-
ated with lower efficiency in the provision of skilled birth attendance and DPT immunization,
these results are not robust to specification changes where governance and institutional indica-
tors are included (column 3; see also Tables A9 and A10 in S1 Appendix). Similarly, there is
only preliminary indication that better governance is associated with higher efficiency in pro-
viding access to necessary services for the general population. The coefficient on the average
governance quality indicator is positive and statistically significant for skilled birth attendance
and DPT immunization in column (2) but not in the full model (3). In spite of this lack of sta-
tistical significance in the full model, the link between governance and efficiency in service
access is also found in further models where the health system institutional variables are exam-
ined individually instead of using an average index (Tables A9 and A10 in S1 Appendix, col-
umn 16). As a sense of the magnitudes involved, the results imply that if Panama were to
improve its governance index to reach the level of Uruguay, the associated increase in Pana-
ma’s DPT immunization efficiency score would be equivalent to an increase of two percentage
points in its DPT immunization rate, from the observed 81% to 83%, for the same level of pub-
lic health spending.
For health system institutional quality, despite the lack of statistically significant results
in the main models, an examination of the estimated coefficients for each of the institutional
sub-indicators suggests a more nuanced picture, specifically for skilled birth attendance mea-
sures (see Tables A9 and A11 in S1 Appendix, columns 16–17). For skilled birth attendance
provision and its ratio poorest/richest, there is indication that the extent of results-based
management in the production of healthcare goods and services correlates with higher effi-
ciency in providing both broader and more equitable service coverage. This positive result is
counterbalanced in both cases by negative and statistically significant point estimates for the
sectoral information systems variable, thus leading to point estimates for the average health
system institutional quality variable that are positive yet relatively small and not statistically
significant.
Further robustness checks
In addition to the results for 17 alternative Simar-Wilson regression specifications for each
output presented in S1 Appendix, in this section we further explore the robustness of our pre-
vious results to changing the key DEA input of interest for assessing efficiency, from public
health expenditure to either (i) total health expenditure per capita or (ii) pooled prepaid health
expenditure per capita. We compute revised DEA scores for cases (i) and (ii) separately and
then run Simar-Wilson cross-sectional regressions as described previously. To save space, we
present the full results of these analyses in S1 Appendix: Tables A13-A20 (total health expendi-
tures) and Tables A21-A28 (pooled health expenditures).
Using total health expenditures as the main DEA input: Results. Moving to total health
expenditure as DEA input again suggests that governance quality is linked to cross-country
differences in service coverage efficiency: the results of the re-estimated Simar-Wilson regres-
sions for the provision of skilled birth attendance and DPT immunization provide some
additional indication in that respect (Tables A17 and A18 in S1 Appendix). The noteworthy
change relative to our main regression results occurs for the skilled birth attendance ratio
poorest/richest (Table A19): higher governance quality is now also linked to higher efficiency
in providing more equitable access to skilled birth deliveries. On the other hand, the models
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with total health spending are once again unable to pick up any robust relationship between
system efficiency and our system organizational variables, or average health system institu-
tional quality.
Using pooled health expenditures as the main DEA input: Results. For this robustness
check we change the main DEA input to pooled prepaid health expenditure per capita, defined
as public (government) spending on health plus voluntary health insurance payments. This
spending aggregate refers to funds paid by citizens before the need for medical care through
sources such as taxation, social health insurance contributions and voluntary insurance plans.
The causal influence of such pooled funds for improvements in access and population health
has been established at the cross-country level [31, 35]. An argument for the use of pooled
health spending in our analyses, instead of just public expenditures on health, is that in princi-
ple the consequent access and health improvements from better or higher spending on health
can arise regardless of who makes the prepayment. Furthermore, within the wider context of
push for UHC and progress around SDGs, pooled health financing indicates the prepaid
resources that a nation is directly devoting to financial risk protection and effective access in
the health sector, as opposed to out-of-pocket health payments made directly to providers at
the point of service use. Therefore, measuring health system efficiency with respect to pooled
spending frames the discussion more directly around how countries can target efficiency gains
as a way to make better progress towards UHC.
The positive link between governance quality and health system efficiency is apparent once
more when pooled health expenditure is used as the main input. In particular, the new regres-
sion results confirm a positive and statistically significant relationship between average gover-
nance quality and efficiency concerning under-five mortality achievement (Table A23 in S1
Appendix, columns 2–3). The estimated governance coefficients and standard errors have sim-
ilar magnitudes to the corresponding estimates from the models using public health spending
or total health spending per capita (the latter are only marginally statistically insignificant).
The estimated governance effect is also positive and statistically significant for efficiency in
DPT immunization coverage (Table A26 in S1 Appendix, column 2). Similarly to the case of
total health expenditures, the regressions for pooled health expenditures suggest that higher
governance quality is linked to higher efficiency in providing more equitable access to skilled
birth attendance (Tables A27-A28 in S1 Appendix). The regressions for pooled health spend-
ing also lend some additional support to the suggestion that better health system institutions
are associated with higher efficiency in service coverage judged by skilled birth attendance
(Table A25 in S1 Appendix, column 3). As before, there is no robust relationship identified
between efficiency and the out-of-pocket expenditure or beds per population proxies.
Estimations using a robust conditional approach: Results. Previous research has argued
that, in spite of two-stage DEA approach being a commonly employed method to assess effi-
ciency and its determinants, its ability to provide reliable inference depends on the validity of
the key underlying assumption of ‘strong separability’, i.e. that the ‘environmental’ variables
(in our case, the potential health system efficiency determinants) affect the distribution of inef-
ficiencies but not the location of the production frontier [7, 38]. In order to explore whether
our main empirical conclusions are changed should the ‘strong separability’ assumption fail
in our context, we re-estimate our models using conditional order-m efficiency estimators,
whereby the estimation of the efficiency frontier and of potential efficiency determinants is
undertaken simultaneously, non-parametrically and with better convergence properties
than with other DEA estimators; for details see [7] (we thank an anonymous referee for
this suggestion). We perform a separate conditional order-m efficiency estimation for each of
our eight output variables. The variables included as inputs in each model are, in addition to
public health spending per capita, GDP per capita and population aged 65 and above. As
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environmental variables we include the out-of-pocket health spending share, hospital beds,
the average governance index and the average health system institutional quality index. The
results of the conditional order-m estimations are shown in Table A29 and Figs A1-A8 in S1
Appendix.
Overall, the new estimations actually strengthen our conclusion that both better governance
and higher quality of health institutions are associated with higher health system efficiency.
For the eight outputs, we find that better average governance is linked to better efficiency
performance, in most cases at the 1% level of statistical significance. We also find that higher
quality of health institutions is unequivocally and statistically significantly linked to better effi-
ciency scores with respect to key indicators of health (life expectancy at birth and under-five
mortality), access to care (DPT immunization) and equity of access (the rural/urban ratio of
skilled birth attendance), at the 5% statistical significance level or lower.
The only noteworthy changes to our main conclusions refer to the relationships of effi-
ciency with our proxies for the organization of healthcare financing and delivery. Firstly, the
conditional order-m models find that health systems that rely less on out-of-pocket spending
(as share of total health expenditure) tend to produce better health outcomes for a given level
of health financing, judged by all our indicators of life expectancy, mortality and morbidity.
This lends some support to previous findings that pooled prepaid financing is normally more
efficient in producing better population health than OOP health financing [35]. Secondly, the
new estimates suggest that higher numbers of hospital beds per person are associated with
higher system efficiency in generating better health (except mortality), service access (DPT
immunization) and equity of access (ratio poorest/richest of skilled birth attendance), which
could be interpreted as a general indication that higher health system efficiency is linked to
wider availability of health infrastructure for the population.
Taken together, the results of the conditional order-m estimations strongly reinforce the
conclusions of the main analyses regarding the positive relationship between health institu-
tional quality and general governance on the one hand, and health system efficiency on the
other. If anything, our main (two-stage) estimation approach is in fact providing lower bounds
of efficiency effects, particularly for the potential influence of health institutional variables. In
the Discussion section below, we therefore focus mostly on the results of our main two-stage
analyses for all potential efficiency determinants so as to remain on the more “conservative”
side.
Discussion and conclusions
The first message from our analyses is that there appears to be substantial room for efficiency
improvements in the health system of most LAC countries. For example, LAC countries could
improve life expectancy at birth by about 5 years on average at current spending levels if they
followed best practices. This magnitude is larger than the comparable estimate of about 3 years
for LAC countries found by Grigoli and Kapsoli [18] (it is in fact similar to their estimate of
potential average gain found for African economies) and much larger that an estimate of 1.8
potential extra years on average for OECD countries [8]. Furthermore, despite relatively good
efficiency performance for under-five mortality and life expectancy at age 60, LAC health sys-
tems perform especially poorly compared to OECD ones and other MICs regarding the provi-
sion of equitable access to services for their levels of health spending.
These potential efficiency gains should be sought not only as a matter of public sector
accountability (since health financing in most LAC countries relies heavily on public sources),
but also because the resulting health gains could represent a crucial step in the progress of less
efficient countries towards UHC. However, advocating reductions in health spending in LAC
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to achieve these efficiency gains is not a policy implication arising from our analyses. The fact
that even the highest health spenders in LAC are not necessarily close to a ‘health production
frontier’ (e.g. defined by the health attainment of OECD countries) means that reducing
current health expenditure levels–a key input to enhance the quantity and quality of health
services–would likely be counterproductive for health development in the region [31, 35].
Instead, the policy implication for health system efficiency is that LAC countries should seek
ways to improve the health outcomes and coverage indicators achieved for their current levels
of resources, rather than seek to reduce their health expenditure levels, which are already low
compared, for instance, to OECD countries. Improving population health and equitable access
to services by spending currently available resources more wisely represents a ‘low-hanging
fruit’ for health financing in LAC, which can be used to relieve acute budgetary constraints, as
well as to make a stronger case for increases in the share of government resources devoted to
the health sector.
A second message from our study is that efforts to increase health system efficiency could
be focused in a few key policy areas linked empirically to cross-country efficiency variations in
LAC, including general governance aspects. The relationship between better governance and
higher system efficiency is apparent in several of our estimations, both in the main analyses
and robustness checks. A closer look at the most efficient OECD and MIC peers reveals that
these countries score highly in aspects such as government effectiveness; transparency and citi-
zens’ participation in policymaking; and regulatory quality. All these factors are likely to favor-
ably influence the functioning and efficiency of the public sector [36], which plays a pivotal
role for the organization and functioning of most health systems in LAC. Some of the more
health efficient LAC countries have indeed made important advances in improving public
sector regulation, transparency and accountability to citizens–for instance, by embarking in
sensible open government reforms–and these may make policymaking and public spending
processes more efficient. In Costa Rica, the implementation of a General Comptroller’s Office
web-based tool allowing citizens to monitor public spending is believed to have favored better
public spending targeting, through fostering citizens’ engagement and social control of gov-
ernment expenditures [39]. Similar initiatives have been adopted in Chile and Uruguay, and
may be behind these countries’ relatively high public sector efficiency performance–and health
sector efficiency–within the region [40]. The experiences of Chile, Costa Rica and Uruguay of
developing an e-government system and advancing on e-procurement processes could offer
leads to other LAC countries about promising initiatives for improving governance and public
spending efficiency in healthcare.
A third takeaway message from our empirical results is that greater health system efficiency
in LAC could also be stimulated by improvements in specific dimensions of the quality of
health system institutions. The general importance of health institutions for system efficiency
is suggested somewhat more conservatively in the main estimations, yet it is reinforced, and
clearly strengthened, in our more disaggregated analyses and robustness tests. The most com-
pelling evidence about the importance of particular health institutions refers to the positive
association of efficiency in the provision of broader and more equitable access to health ser-
vices with stronger reliance on results-based management in the production of healthcare
goods and services. The results-based management indicator examined here is a composite
measure encompassing performance within different sub-areas of the public healthcare sys-
tem. A key set of these sub-areas is the planning and active monitoring of annual/multi-annual
targets for the provision of healthcare goods and services, which seems to highlight the poten-
tial benefits of initiatives to incorporate a medium-term perspective in the general and health
budgets. Many OECD countries including Korea–which is often identified in our DEA estima-
tions as an efficient peer for ‘high-spender’ LAC countries–have implemented sound medium
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term expenditure frameworks (MTEFs) to help manage expenditures across government sec-
tors and ensure fiscal discipline, as well as to give ministries time to adjust and better plan
operations. The Korean five-year MTEFs, for example, are perceived to have improved fiscal
responsibility, spending planning capacity, and spending efficiency across all areas of govern-
ment [41, 42]. In LAC, Costa Rica has also made improvements to planning processes particu-
larly around benefit package expansions and human resource management, in a bid to boost
both the efficiency and equity of health spending by the single insurer [39]. This may already
have been reflected at least in part in the country’s relatively high system efficiency scores for
the provision of general and equitable health service coverage. Experience shows, however,
that how a medium-term planning process is actually adhered to (and used to inform deci-
sions) is far more relevant for improving efficiency performance than whether there is any
medium-term planning in place. General characteristics shared by successful experiences
include clear and transparent criteria to identify spending priorities, and implementation of
annual reviews of sector-level progress [43].
Another sub-area included in our results-based management indicator is the presence of
personnel remuneration and evaluation systems that incentivize results. In this regard, our
results concur with findings for OECD countries linking well-designed performance-based
provider payment systems with efficiency gains [37]. Chile and Uruguay, two of the most effi-
cient LAC health systems, have both adopted some degree of pay-for-performance, notably for
the reimbursement of primary care personnel in the public sector (e.g. risk-adjusted capitation
complemented by performance-based payment in Uruguay). This is a particularly relevant
area for policy action in the LAC region, where several health systems rely primarily on reim-
bursement methods that do little to stimulate efficient healthcare spending, such as fee-for-ser-
vice schemes operating within soft budgets [44].
By using LAC data to assess the issues above, this study goes one step further than much of
the available literature towards assessing what (policy-amenable) factors act as the main possi-
ble determinants–and to what extent–for some countries to be able to translate a given level of
health financing into better performance on access and health outcomes, than that achieved by
other countries. We use robust regression methodologies and explicitly examine indicators of
overall and equitable access to services, which is crucial for health policy in LMICs (and specif-
ically in LAC), unlike previous studies that have tended to focus exclusively on population
averages of mortality or life expectancy measures. Nevertheless, as with any empirical work,
our study has limitations imposed by unavoidable methodological choices and data con-
straints. Firstly, in examining empirically some potential determinants of cross-country differ-
ences in health system efficiency, the key word is ‘potential’. Although it seems sensible in
theory to expect factors like governance and health institutions to influence system efficiency
directly, with our data we cannot ascertain whether the estimated relationships do indeed rep-
resent causal links. We can only claim that our Simar-Wilson estimates reflect associations in
the data, suggesting that the efficiency performance of LAC countries and some of its potential
determinants move together systematically. Country-case studies based on ‘natural experi-
ments’ and finer data would be better positioned to identify causal relationships. Notwith-
standing this caveat, it is reassuring that our estimates of links between health system
efficiency and key potential determinants generally follow the direction one would expect for
these relationships, based on theory and available evidence for other contexts.
Secondly, analytical constraints imposed by data availability for LAC countries have been
alluded to in previous sections and are a general issue among LMICs. Stepped up efforts by
international organizations are needed to compile comprehensive and harmonized data over
time on health system spending, throughput and outcome indicators, disaggregated among
others by levels of care provision and population groups, to allow more comprehensive
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analyses of health system performance. Data disaggregated at these levels are typically unavail-
able as comparable time series for LMICs. A final and crucial data issue for our analyses has
been limited information about the institutional characteristics of LAC health systems. Despite
being helpful (and a step ahead of what is available for most LMICs), the PET (PRODEV)
health institutional dataset that we examine for LAC was designed with the aim of evaluating
countries’ capacity to adopt results-based public management, and not specifically to offer a
comprehensive assessment of health system organization and functions across LAC countries.
The sectoral information systems indicator, for instance, refers primarily to the mere existence
of any such system in a given country, which may help explain some counterintuitive empirical
results for that variable.
Surveys that collect harmonized information on health system characteristics across several
countries have represented useful tools for investigations of the main drivers of health expen-
ditures and system efficiency in other settings. A notable example is the Health Systems Char-
acteristics Survey in the case of OECD countries [5, 22]. This collects information on aspects
including the organization of healthcare financing and delivery, provider payment schemes,
user choice, regulation of healthcare supply and prices, and use of health technology assess-
ment, among many others. Similar surveys for the LAC region would enable future compari-
sons of health system efficiency to offer more granular evidence to better inform policy. For
example, some ‘efficient’ LAC countries (e.g. Chile, Uruguay) have moved away from historic
budgets and/or uncapped fee-for-service schemes to pay hospitals, which tend to encourage
inefficient resource use (cf. [37] for a review), towards case-based reimbursement alongside
pay-for-performance elements. Similarly, although LAC health systems in general are still
heavily reliant on specialist, hospital-based and more expensive curative care, relatively effi-
cient LAC health systems including Costa Rica and Uruguay have long offered comprehensive
primary care coverage to citizens, while Chile introduced reforms in 2005 to reinforce cost-
effective primary care as the center of healthcare networks [44]. Unfortunately, without sys-
tematically collected and comparable time series data for most LAC countries on aspects like
health spending and provision by levels of care, or provider reimbursement arrangements, we
are unable to move from preliminary speculation about the link between said institutional fac-
tors and system efficiency, toward finer policy guidance on these particular issues based on
empirical evidence. We believe, however, that the empirical analyses that we are able to under-
take in this study do offer policy-relevant insights for countries seeking to increase efficiency
in the use of existing health resources and reduce cost pressures in the health system, while still
making progress towards UHC/SDG goals and better population health.
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